Catalyst Wire Dossier Catalyst Wire Dossier

Amycretin

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amycretin, covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity [Phase 1]

See pricing